Gluten contamination in the Canadian commercial oat supply by Koerner, T.B. et al.
Food Additives and Contaminants
Vol. 28, No. 6, June 2011, 705–710
Gluten contamination in the Canadian commercial oat supply
T.B. Koerner
a*, C. Cle ´ roux
a, C. Poirier
a, I. Cantin
a, A. Alimkulov
b and H. Elamparo
c
aBureau of Chemical Safety, Food Directorate, Health Canada, 251 Sir Frederick Banting Driveway, Ottawa, ON, Canada K1A
0L2;
bWestern Regional Laboratory, Health Canada, 3155 Willingdon Green, Burnaby, BC, Canada V5G 4P2;
cOntario Food
Laboratory, Health Canada, 2301 Midland Avenue, Toronto, ON, Canada M1P 4R7
(Received 3 December 2010; final version received 6 April 2011)
A growing body of evidence suggests that a majority of people with celiac disease and on a gluten-free diet can
safely consume pure oats in moderate amounts; however, previous studies have indicated that the commercial oat
supply in other countries, and in Canada to some extent, is contaminated with other grains. This study has
confirmed that the commercial oat supply in Canada is heavily contaminated with gluten from other grains.
Approximately 88% of the oat samples (n¼133) were contaminated above 20mgkg
 1 and there were no
differences between the oat types tested. Only one gluten-free variety of oats was analysed and it consistently
provided negative results in all analyses. It is difficult to determine where the contamination originates, but there
are possibilities for cross-contamination in the field, in the transport of the grain, in the storage of the grain, and
in the milling and packaging facilities. It is clear from this study that only those products that have been certified
‘pure’ oats would be appropriate for a gluten-free diet.
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Introduction
Food allergies and intolerances are two sensitivities
that, although they have distinct physiological path-
ways, require the strict avoidance of specific triggering
substances. Wheat is one of these triggers and is among
the eight most common food allergens identified by the
Codex Alimentarius (Codex Alimentarius Commission
2010). Overall, food allergies affect approximately 5%
of young children and 3–4% of adults (Sicherer and
Sampson 2010). Prevalence data from adult and
paediatric clinical populations suggest that wheat
allergy can range from 2.5% in one American study
to 25% of the allergenic population in one study from
France (Hischenhuber et al. 2006). Adverse reactions
to wheat can be severe, such as wheat-dependent
exercise-induced anaphylaxis, but reactions can also
include respiratory (e.g. bakers’ asthma), contact
(e.g. atopic eczema/dermatitis), or gastrointestinal
problems such as irritable bowel syndrome and ulcer-
ative colitis (Battais et al. 2005). Celiac disease is an
inherited autoimmune disease that results in an intol-
erance not only to wheat, but also to other cereals such
as barley and rye. It is estimated to affect approxi-
mately 0.5–1.0% of people in developed countries
(Catassi and Fasano 2008) and its prevalence is on the
rise (Rubio-Tapia and Murray 2010). Fortunately,
withdrawal of the gluten-containing foods from the
diet can, in most cases, reverse this damage and a
significant recovery of the intestinal mucosa is
observed (Farrell and Kelly 2002).
Given the ubiquitous presence of these cereals in
the Western diet (e.g. pasta, breakfast cereals, most
breads, thickeners and stabilizers used in soups,
processed meats, etc.), the strict avoidance of wheat
and other sources of gluten is a lifetime challenge
(Rashtak and Murray 2009). Individuals on a gluten-
free diet need to replace these cereals with products
derived from naturally gluten-free cereal grains
(e.g. rice, corn, buckwheat, sorghum, etc.), but the
recommended amounts of fibre, iron and calcium can
be more difficult to obtain on such a diet and good
planning is required (Thompson et al. 2005). Oats are
known to be a source of both soluble and insoluble
dietary fibre, B-complex vitamins (thiamin, niacin and
riboflavin), iron and proteins (Thompson 2003;
Haboubi et al. 2006). However, the safety of oats as
part of a gluten-free diet has been an object of
debate because there is evidence to indicate some
individuals with celiac disease are intolerant to oats in
addition to wheat, barley and rye (Silano et al. 2007).
The complexity of celiac disease along with a certain
homology in the protein fraction of oats with other
gluten-containing cereals is likely to be the reason why
some individuals react to oats. However, there is a
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oats and the immuno-stimulatory protein sequences
found in wheat, rye and barley which may explain why
most people with celiac disease are able to tolerate
these cereal grains (Pulido et al. 2009). In fact, there is
a growing body of evidence to suggest that pure oats
(uncontaminated with other gluten-containing cereal
grains) are safe to consume in moderate amounts for
the majority of people suffering from celiac disease and
would be very important source of proteins, carbohy-
drates and fibre (Rashid et al. 2007).
Canada has established requirements for the pro-
duction of uncontaminated oats including the growing,
processing, testing and labelling stages of the product.
It cannot be assumed that all varieties of oats sold in
Canada are uncontaminated with other gluten sources
because the infrastructure used for growing, transport-
ing and milling of other grains may be used for oats
and cross-contamination is likely to occur. There have
been a few studies that have shown the likelihood and
levels to which oat varieties are contaminated with
other gluten-containing cereals, but most of these
investigations were on oats sold in the United States
and Europe and only two had limited information on
varieties sold in Canada (Thompson 2004; Hernando
et al. 2006, 2008; Ge ´ linas et al. 2008). To obtain a
better picture of gluten contamination within the oat
varieties sold at Canadian retailers we collected a large
sampling from across the country for a variety of
different oat products.
Materials and methods
Food samples
Oat samples were collected from retail outlets in
Newfoundland, Prince Edward Island, Quebec,
Ontario and British Columbia at two different times
in the year to ensure that at least two samples with
distinct lot codes could be collected. Mixing four
samples of each lot in a large bowl by hand produced
a composite material, of which approximately 1kg was
finely ground to between 100 and 200 microns using a
centrifugal mill (Retsch Mill ZM 200, Haan, Germany).
The milled samples were then homogenized by mixing
for 30min with a 1000W industrial stand mixer
(Cuisinart, Model #SM-70C) to produce a finely
ground homogenized composite oat material. A 200g
subsampling of this material was then stored for
analysis. The centrifugal mill and the stand mixer
components were disassembled between samples for
cleaning with copious amounts of hot water and
allowed to air dry. Samples collected in British
Columbia were processed in a slightly different
manner (n¼35 of 133). Composite samples of approx-
imately 500g were milled using a commercial blender
(Waring, Torrington, CT, USA) before homogeniza-
tion with a bottle roller.
ELISA systems
Gluten analysis was performed in duplicate using the
RIDASCREEN R-7001 gliadin ELISA (R-Biopharm
Inc., Washington, MO, USA). This kit performs the
quantitative analysis of prolamins from wheat (glia-
dins), barley (hordeins) and rye (secalins). The gliadin
standards supplied with the kit are calibrated to the
Prolamin Working Group reference material with a
limit of detection of 3mg of gluten per kg of sample
and a quantification range for gluten from 5 to
80mgkg
 1 (Van Eckert et al. 2006). The kit instruc-
tions were followed for this analysis and the procedure
is only briefly described here. The nature of the oat
flour samples did not require any special extraction
solutions so the ethanol extraction process described in
the kit insert was used for the analysis. Each sample of
oats (1.0g) was weighed into a 15ml centrifuge tube, a
60% aqueous ethanol solution (10ml) was added and
the tubes were put on a vortex for 30s. Samples were
mixed for an additional 10min on a shaker (VWR
0S-500) followed by centrifugation at room tempera-
ture for 10min at 2500g (ThermoFisher Sorvall RT-1).
A measured aliquot of the supernatant was removed;
diluted 50 times and then 100ml of this solution were
used in the assay. Standards and samples were added in
duplicate wells on the plate and allowed to incubate for
30min at room temperature followed by three washing
steps. Enzyme conjugate was added to each well and
the plate was incubated for 30min followed by an
additional three washing steps. At this point substrate
and chromogen were added to each well and allowed to
react for 30min followed by the addition of stop
reagent. The absorbance was read at 450nm and the
data analysed to determine gluten concentration.
The plate results are given in gliadin concentration
and need to be adjusted for the dilution factor to
obtain the gliadin concentration in solution, which is
then converted to gluten content by multiplication by
two. All samples that showed an absorbance value over
the highest standard were further diluted until the
results were within the calibration range.
An ELISA from Tepnel Biosystems (BioKits line of
ELISA kits are now being distributed by Neogen,
Lansing, MI, USA; http://www.neogen.com) was used
to screen a subset of the original samples for barley
contamination. This particular kit uses an antibody
that recognizes !-gliadin, which has a low cross-
reactivity to barley hordeins (5%) compared with
wheat gliadin (100%). The limit of detection for this
assay is 1mgkg
 1 of material and the quantification
range is from 3 to 50mgkg
 1 of gluten in a sample.
706 T.B. Koerner et al.Results and discussion
There is scientific evidence to support the introduction
of moderate amounts of pure oats in the gluten-free
diet of individuals suffering from celiac disease (Pulido
et al. 2009). Pure oats are recommended because it is
believed, and has been shown to some extent, that the
commercial oat supply is contaminated with other
grains. In order to determine the extent of this
contamination we analysed a large selection of pack-
aged oat products that are readily available in the
Canadian retail market. Figure 1 shows the gluten
levels determined for the oat composites tested in this
study using the RIDASCREEN R-7001 sandwich
ELISA (R5-ELISA). Of the 133 samples analysed only
nine (6.8%) were found to contain levels of gluten
below the 20mgkg
 1 limit proposed by the Codex
Alimentarius Commission for naturally gluten-free
foods (Catassi and Fasano 2008). Three of these
samples had undetectable amounts of gluten, while
the remaining samples were between 5 and 20mgkg
 1.
The remaining samples (n¼124, 93.2%) showed con-
tamination levels above this limit and ranged from
approximately 21 to 3800mgkg
 1. Previous studies
that have measured the gluten content in oats had a
limited number of samples from the Canadian market,
but showed similar contamination levels to this study.
For example, one study found eight of 12 samples of
oats purchased in Canada (67%) were contaminated
(Ge ´ linas et al. 2008) while another found that seven of
ten samples purchased in Canada (70%) were
contaminated with gluten at levels higher than
20mgkg
 1 (Hernando et al. 2008).
Another aspect of this study that is of interest is the
variance within different lots of commercial oats sold
in Canada. Is it possible to find a brand of oats that is
consistently low in gluten? As mentioned above there
were three samples of oats that showed undetectable
levels of gluten using the R5-ELISA. Two of these
samples were different lots from the one company and
the last sample was part of a set of six different lots of
rolled oats from a different company. The former two
lots of oats from one company tested negative for
gluten while the six lots from the other company
ranged from zero to 133mgkg
 1 of oats. This was not
an isolated example and all oat types showed variance
within the different lots sold in Canada. The variability
between different types of oats available on the
Canadian market was also investigated by determining
the average gluten level for the different types of oats
(Table 1). Analysis of variance (ANOVA) for the
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Figure 1. Survey results of the average gluten levels in a sampling of pre-packaged oats sold in Canadian retail stores using a
commercial ELISA kit. The insert is an expanded region of the lower-level samples along with a line representing the 20mgkg
 1
level recommended by CODEX for gluten-free status.
Table 1. Gluten content as a function of type of oat
product.
Type of oat
Range
(mgkg
 1)
Median
(mgkg
 1)
Mean
(mgkg
 1)
Steel-cut oats 55–1467 660 645 512
Rolled/flaked/
oatmeal
0–2485 81 316 497
Quick/minute oats 13–3784 534 655 694
Oat bran 37–3469 280 704 862
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cant difference between the oat types ( ¼0.06).
Interestingly, analysis of the data obtained for regu-
lar and organic oats shows that there is a signifi-
cant difference ( 50.0001) between organic
oats (mean¼240mgkg
 1,n¼31) and regular oats
(mean¼616mgkg
 1,n¼102), but this crop is still
significantly contaminated with gluten.
In order to determine the type of grain that has
contaminated the oat samples a selection of oat types
purchased were analysed again using an ELISA
method that is insensitive to barley hordeins.
The R5-ELISA responds to a peptide sequence that
is present in gliadin and then reports the amount of
gluten by referencing to a gliadin material based on
multiple wheat cultivars (Van Eckert et al. 2006).
This assay also responds to barley and rye because the
same peptide sequence is present in hordeins and
secalins; however, the gluten assay that responds to the
!-gliadin fraction of wheat has a low cross-reactivity
(5%) towards barley hordeins. A high response from
the R5-ELISA and a low response from the !-ELISA
is an estimate of the type of gluten contamination
(Ge ´ linas et al. 2008). For example, the level of gluten
for sample 63 (Figure 2) using the R5-ELISA was
determined to be 216mgkg
 1 while the level for the
same sample using the !-gliadin ELISA was only
10mgkg
 1. The response from the !-ELISA is
approximately 5% of the R5-ELISA and suggests
that barley is the source of the gluten contamination
for this sample. In another example, sample 36
reported 59mgkg
 1 using the R5-ELISA and
16mgkg
 1 using the !-ELISA, suggesting the gluten
contamination is likely a mixture of wheat and barley
or possibly differences in the !-gliadin content of
sample. The data in Figure 2 indicate that the majority
of samples (13 of 14) in the subset that tested positive
for gluten were contaminated at some level with barley.
Although individuals with gluten sensitivities also react
to the hordeins in barley, the actual level of gluten in
the sample, measured by the R5-ELISA, can be
overestimated due to the differences between barley
and wheat, the latter of which has been used to
calibrate the method (Kanerva et al. 2006). Canadian
regulations do not require allergen labelling of grains
like oats that are destined for further processing and
allow the presence of a certain percentage of foreign
components, which may include gluten-containing
cereals (Canadian Grain Regulations 2008).
Packagers of oats can voluntary provide precautionary
statements to warn allergic or intolerant consumers
about the potential risk of cross-contamination. The
results of this study have shown that precautionary
labelling practices of commercial oats vary greatly
(Table 2). For example, the oat products tested either
had no precautionary statement pertaining to wheat or
gluten (n¼65) or presented various statements ranging
from, ‘may contain traces of wheat’ (n¼43) to less
clear statements such as ‘good manufacturing practices
have been used to segregate ingredients in a facility
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Figure 2. Results for the determination of gluten source for a subset of samples using two different ELISA kits.
Table 2. Number of occurrences for different precautionary
statements.
Precautionary statement Number of occurrences
No warning 65
Wheat-free claim 2
May contain wheat or traces
of wheat
43
May contain other allergens
a 9
Manufactured in a facility that
also uses wheat, etc.
b
11
Wheat starch in the ingredient list 3
Notes:
aExample: ‘May contain traces of nuts and milk
ingredients.’
bThis also includes the following statement: ‘Good
manufacturing practices have been used to segregate ingre-
dients in a facility that also processes peanuts, tree nuts, milk,
eggs, wheat, sulfites and soy ingredients.’
708 T.B. Koerner et al.that also processes peanuts, tree nuts, milk, eggs,
wheat, sulfites and soy ingredients’ (n¼11). The latter
statement is confusing and contains some uncertainty
for many individuals with food allergies (Verrill and
Choiniere 2009) and may be a reason why precaution-
ary statements are increasingly being ignored by
allergic consumers (Sheth et al. 2010). A concern to
no precautionary statement, or an ambiguous one, is a
precautionary statement that provides an incom-
plete list of allergens potentially present through
unavoidable cross-contamination. For example, some
of the oat samples contained statements indicating the
potential presence of other allergens including peanut,
tree nuts, sesame and soy, but not for wheat or
gluten. Given the increased knowledge of potential
cross-contamination a consumer will likely know that
these products will still be contaminated with gluten.
The only sample that was gluten free in both lots that
were tested actually had a wheat-free claim on the
package and represents a pure oat product. In regard
to oat varieties in Canada it would be suggested that all
warnings should be adhered to and avoidance of all
commercial oat varieties other than pure oats be
followed. Although there were some varieties of pre-
packaged oats that were low in gluten the vast majority
would not be safe for the allergenic or intolerant
consumers.
Conclusions
This study was done to determine the extent of the
contamination of the commercial oat supply in
Canada. Oat samples were collected from retail stores
across the country and at different times in the year to
ensure two different lots were obtained for each
product. Taking into consideration the lot-to-lot var-
iability, approximately 88% of the products tested
were contaminated above the Codex-recommended
gluten-free level and ranged from 21 to 3800mgkg
 1
of oats. There was little difference in the level of gluten
between the processed types of oats, but the organic
varieties (mean¼240mgkg
 1) did have a statistically
significant lower level of gluten compared with the
regular variety of oats (mean¼616mgkg
 1). Although
the organic varieties of commercial oats contain lower
levels of gluten they still would not be considered
gluten-free or safe. Further analysis on a portion of the
samples collected using a method that is known to have
a low sensitivity to barley hordeins indicated that many
of these samples were likely contaminated with barley.
Only one sample of oats consistently produced nega-
tive results using both ELISA methods and this sample
contained a wheat-free claim on the package. The pure
variety of oats, those that have been determined
experimentally to be gluten-free, are the only variety
that are recommended for someone following a gluten-
restrictive diet. This study also showed that voluntary
precautionary labelling was used on roughly half of the
products tested and in some cases the statement was
inadequate. Therefore, educational initiatives are
important in communicating the risk of gluten con-
tamination in naturally gluten-free cereal grains such
as (regular) commercial oats. Initiatives are underway
to collect data on the gluten contamination of other
naturally gluten-free cereal grains in Canada, which
may have an important impact on the consumption
patterns of individuals with celiac disease or wheat
allergy in Canada.
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